Lucid, inc.

Published purpose

LUCID, a Canadian digital health startup, and Emma Healthcare, a Korean SME specializing in advanced diagnostics, are collaborating to revolutionize neuropsychiatric care through the co-development of an AI-based music therapy solution. LUCID's BioMIR technology, which analyzes user data and predicts emotional and cognitive states to personalize digital music therapy, will be enhanced with Emma Healthcare's diagnostic capabilities and measurement expertise. This joint effort aims to optimize the effectiveness of the therapy offering by training it on diverse datasets from North American and Asian populations, ultimately providing personalized, clinically validated music therapy solutions for improved mental well-being worldwide.